Liên Minh Châu Âu - Tiếng Phần Lan - EMA (European Medicines Agency)

biocryst - peramivir - influenssa, ihminen - antiviraalit systeemiseen käyttöön - alpivab on tarkoitettu hoitoon mutkaton influenssa aikuisille ja lapsille iästä alkaen 2 vuotta.

Liên Minh Châu Âu - Tiếng Phần Lan - EMA (European Medicines Agency)

mundipharma corporation (ireland) limited - pegfilgrastiimia - neutropenia - immunostimulantit, - vähentää neutropenian kestoa ja kuumeisen neutropenian esiintyvyyden vuoksi kemoterapiaa.

Liên Minh Châu Âu - Tiếng Phần Lan - EMA (European Medicines Agency)

jazz pharmaceuticals ireland limited - daunorubicin hydrochloride, cytarabine - leukemia, myeloidi, akuutti - antineoplastiset aineet - vyxeos liposomaalista on tarkoitettu hoitoon aikuisilla, joilla on äskettäin diagnosoitu, hoito-liittyvän akuutin myelooisen leukemian (t-aml) tai aml myelodysplasia liittyviä muutoksia (aml-mrc).

Liên Minh Châu Âu - Tiếng Phần Lan - EMA (European Medicines Agency)

medac gesellschaft für klinische spezialpräparate mbh - treosulfan - hematopoieettiset kantasolutransplantaatiot - antineoplastiset aineet - treosulfan in combination with fludarabine is indicated as part of conditioning treatment prior to allogeneic haematopoietic stem cell transplantation (allohsct) in adult patients and in paediatric patients older than one month with malignant and non-malignant diseases.

Liên Minh Châu Âu - Tiếng Phần Lan - EMA (European Medicines Agency)

instituto grifols s.a. - fostamatinib dinatrium - trombosytopenia - muita systeemisiä hemostaatit - tavlesse on tarkoitettu kroonisen immuunitrombosytopenia (itp) aikuisilla potilailla, jotka ovat sietäneet muita hoitoja.

Liên Minh Châu Âu - Tiếng Phần Lan - EMA (European Medicines Agency)

roche registration gmbh - polatuzumab vedotin - lymfooma, b-solu - antineoplastiset aineet - polivy yhdessä bendamustiinin ja rituksimabi on tarkoitettu aikuisille potilaille, joilla oli uusiutunut/vaikeahoitoinen hajanainen suuri b-solu lymfooma (dlbcl), jotka eivät ole ehdokkaita vertamuodostavan kudoksen kantasolujen siirto. polivy in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone (r-chp) is indicated for the treatment of adult patients with previously untreated diffuse large b-cell lymphoma (dlbcl).

Liên Minh Châu Âu - Tiếng Phần Lan - EMA (European Medicines Agency)

sanofi winthrop industrie - isatuximab - multiple myeloma - antineoplastiset aineet - sarclisa is indicated: in combination with pomalidomide and dexamethasone, for the treatment of adult patients with relapsed and refractory multiple myeloma (mm) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor (pi) and have demonstrated disease progression on the last therapy. in combination with carfilzomib and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least one prior therapy (see section 5.

Liên Minh Châu Âu - Tiếng Phần Lan - EMA (European Medicines Agency)

daiichi sankyo europe gmbh - trastuzumab deruxtecan - rintojen kasvaimet - antineoplastiset aineet - breast cancerher2-positive breast cancerenhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic her2-positive breast cancer who have received one or more prior anti-her2-based regimens. her2-low breast cancerenhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic her2-low breast cancer who have received prior chemotherapy in the metastatic setting or developed disease recurrence during or within 6 months of completing adjuvant chemotherapy (see section 4. non-small cell lung cancer (nsclc)enhertu as monotherapy is indicated for the treatment of adult patients with advanced nsclc whose tumours have an activating her2 (erbb2) mutation and who require systemic therapy following platinum-based chemotherapy with or without immunotherapy. gastric cancerenhertu as monotherapy is indicated for the treatment of adult patients with advanced her2-positive gastric or gastroesophageal junction (gej) adenocarcinoma who have received a prior trastuzumab-based regimen.

Liên Minh Châu Âu - Tiếng Phần Lan - EMA (European Medicines Agency)

ecuphar nv - enflicoxib - tulehduskipulääkkeet ja reumalääkkeet - koirat - for the treatment of pain and inflammation associated with osteoarthritis (or degenerative joint disease) in dogs.

Liên Minh Châu Âu - Tiếng Phần Lan - EMA (European Medicines Agency)

diurnal europe b.v. - hydrokortisoni - adrenal hyperplasia, congenital - kortikosteroidit systeemiseen käyttöön - treatment of congenital adrenal hyperplasia (cah) in adolescents aged 12 years and over and adults.